News
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
"The Merck Wilmington Biotech site represents our continued commitment to growing our investments in U.S. manufacturing and has the potential to create thousands of high-paying American jobs while ...
This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Merck is constructing a $1 billion drug ...
Hosted on MSN2mon
Construction begins on MSD’s $1bn biologics centre in Delaware, USMerck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US. The 470,000ft² facility is set to bolster the company's biologics and ...
Merck, known as MSD outside of the United States and Canada, announced the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, ...
(RTTNews) - Merck & Co., Inc. (MRK), Tuesday announced that the company has started construction of state-of-the-art biologics center of excellence worth $1 billion in Wilmington, Delaware ...
Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.
U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs.
It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients. Merck to invest $1 billion in U.S. drug manufacturing plant Skip to main content ...
Merck, known as MSD outside of the United States and Canada, has started construction on a $1bn, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware. A ...
"The Merck Wilmington Biotech site represents our continued commitment to growing our investments in U.S. manufacturing and has the potential to create thousands of high-paying American jobs while ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results